Melanie Kelly
Technik-/Wissenschafts-/F&E-Leiter bei Panag Pharma, Inc.
Profil
Melanie Kelly is currently the Executive Director & Member of the International Cannabinoid Research Society, Director at The Canadian Consortium for the Investigation of Cannabinoids, Professor at Dalhousie University, and Chief Scientific Officer at Panag Pharma, Inc. She was formerly the Chief Scientific Officer at Tetra Bio-Pharma, Inc.
Aktive Positionen von Melanie Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| Dalhousie University | Corporate Officer/Principal | 01.07.1991 |
| International Cannabinoid Research Society | Direktor/Vorstandsmitglied | 01.07.2017 |
| The Canadian Consortium for the Investigation of Cannabinoids | Direktor/Vorstandsmitglied | - |
Panag Pharma, Inc.
 Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2014 |
Ehemalige bekannte Positionen von Melanie Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| TETRA BIO-PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| International Cannabinoid Research Society | |
| The Canadian Consortium for the Investigation of Cannabinoids | |
Panag Pharma, Inc.
Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada. | Health Technology |
